Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · IEX Real-Time Price · USD
8.11
-0.89 (-9.94%)
At close: Jul 2, 2024, 4:00 PM
8.43
+0.32 (4.01%)
After-hours: Jul 2, 2024, 4:46 PM EDT
Tango Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 14.17, with a low estimate of 11 and a high estimate of 18. The average target predicts an increase of 74.83% from the current stock price of 8.11.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 28, 2024.
Analyst Ratings
The average analyst rating for TNGX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 2 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $13 | Strong Buy | Maintains | $16 → $13 | +60.39% | May 28, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +72.73% | May 24, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $13 | Buy | Maintains | $18 → $13 | +60.39% | May 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $18 → $11 | Buy | Maintains | $18 → $11 | +35.72% | May 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +109.75% | May 9, 2024 |
Financial Forecast
Revenue This Year
30.88M
from 36.53M
Decreased by -15.47%
Revenue Next Year
31.62M
from 30.88M
Increased by 2.40%
EPS This Year
-1.41
from -1.08
EPS Next Year
-1.39
from -1.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.3M | 60.6M | 69.1M | 360.2M | 333.6M |
| Avg | 30.9M | 31.6M | 28.8M | 83.4M | 103.6M |
| Low | 22.5M | 19.6M | n/a | 19.6M | 8.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21.3% | 96.2% | 118.5% | 1,151.3% | 300.0% |
| Avg | -15.5% | 2.4% | -9.0% | 189.8% | 24.2% |
| Low | -38.3% | -36.5% | - | -31.9% | -90.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.22 | -1.04 | -1.08 | -0.46 | -1.42 |
| Avg | -1.41 | -1.39 | -1.48 | -1.35 | -1.78 |
| Low | -1.93 | -1.64 | -1.71 | -1.78 | -1.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.